Complex molded parts manufacturer Vaupell Midwest (Constantine, Mich.) announced this week that it has earned MedAccred certification from not-for-profit medtech audit provider MedAccred.
MedAccred is a supply-chain oversight program of the Performance Review Institute. It conducts critical-process audits for its member OEMs to ensure their suppliers adhere to global regulations and requirements, and helps reduce the number of onsite audits for suppliers.
Some of the leading OEMs participating in this program are Bausch Health, Baxter, Bayer, BD, Boston Scientific, Flex, Johnson & Johnson, Medtronic, Philips, Roche Diagnostics, and Stryker.
The MedAccred designation adds Vaupell Midwest to a group of injection molders that have been endorsed to serve the medical industry. MedAccred accreditation entitles an organization to appear on its qualified manufacturers list.
“At Vaupell, we have always been extremely process-oriented,” said Vaupell Midwest plant manager Keith Bridgford in a news release. “We employ a disciplined approach to injection molding using Scientific Injection Molding (SIM). We are a data-driven organization in all we do, and we have a continuous improvement approach to delivering on the quality expectations of our customers in the medical device industry. We highly value the needs of our OEM partners and understand the need for a single-audit criteria program that improves patient safety and ensures superior manufacturing best practices.”
“The audit process dove-tailed very nicely with the processes that we already had in place,” added Vaupell Midwest quality manager Jessica Arseneau. “It allowed us the opportunity to do a full gap assessment of the current and target state of our processes, practices, capabilities, documentation control, and quality systems to better align and simplify the ongoing critical audit process for our long-term OEM partners.”
